Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib.
暂无分享，去创建一个
Amanda R. Campbell | J. Byrd | F. Awan | L. Andritsos | X. Mo | K. Rogers | N. Muthusamy | Jonathan P Butchar | C. R. Lucas | Emily Mcwilliams | W. Carson | S. Tridandapani | C. Cheney | B. Harrington | J. Woyach | R. Wasmuth | E. Hertlein | Timothy L. Chen | Carlos E Castro | Bonnie K. Harrington